We are live on ! Find out more
CEI

Clark Estates Inc Portfolio holdings

AUM $434M Turnover 26.85%
1-Year Est. Return 15%
This Fund
S&P 500
This Quarter Est. Return
-4.03%
1 Year Est. Return
+15%
3 Year Est. Return
+34.46%
5 Year Est. Return
+32.78%
10 Year Est. Return
+216.75%
AUM
$517M
AUM Growth
-$19.9M
Cap. Flow
+$6.83M
Cap. Flow %
1.32%
Top 10 Hldgs %
52.59%
Holding
101
New
11
Increased
7
Reduced
56
Closed
9
Avg Time Held
2.2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1.7 years

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$26.1M
2
DEO icon
Diageo
DEO
+$10.9M
3
SONY icon
Sony
SONY
+$6.33M
4
PDCO icon
Patterson Companies, Inc.
PDCO
+$3.23M
5
HALO icon
Halozyme
HALO
+$3.18M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$4.37M
2
IDCC icon
InterDigital
IDCC
+$3.93M
3
GTES icon
Gates Industrial Corp
GTES
+$3.85M
4
AYI icon
Acuity Brands
AYI
+$3.84M
5
LHX icon
L3Harris
LHX
+$3.83M

Sector Composition

Rank Sector Weight
1 Healthcare 29.19%
2 Miscellaneous 20.54%
3 Technology 14.09%
4 Consumer Staples 13.28%
5 Consumer Discretionary 5.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
WLY icon
26
John Wiley & Sons Class A
WLY
$2.68B
$3.46M 0.67%
79,113
-9,587
-11% -$470K
2023 Q3
5 quarters
SSNC icon
27
SS&C Technologies
SSNC
$19.8B
$3.44M 0.66%
45,399
-5,501
-11% -$412K
2023 Q4
4 quarters
SWI icon
28
DELISTED
SolarWinds Corporation Common Stock
SWI
$3.37M 0.65%
236,315
-28,635
-11% -$386K
2024 Q1
3 quarters
INCY icon
29
Incyte
INCY
$23B
$3.34M 0.64%
48,298
-5,852
-11% -$417K
2024 Q2
2 quarters
GILD icon
30
Gilead Sciences
GILD
$195B
$3.32M 0.64%
35,930
-4,345
-11% -$391K
2019 Q3
21 quarters
ZD icon
31
Ziff Davis
ZD
$2B
$3.23M 0.62%
59,491
-7,209
-11% -$378K
2023 Q2
6 quarters
INDV icon
32
Indivior Pharmaceuticals
INDV
$3.97B
$3.2M 0.62%
257,400
+3,300
+1% +$33.9K
2024 Q3
1 quarter
REZI icon
33
Resideo Technologies
REZI
$2.52B
$3.14M 0.61%
136,397
-16,528
-11% -$388K
2022 Q1
11 quarters
LNTH icon
34
Lantheus
LNTH
$6.53B
$3.12M 0.6%
34,874
-4,226
-11% -$412K
2024 Q2
2 quarters
TAP icon
35
Molson Coors Class B
TAP
$7.28B
$3.07M 0.59%
53,515
-6,485
-11% -$378K
2024 Q1
3 quarters
FTDR icon
36
Frontdoor
FTDR
$5.39B
$3.06M 0.59%
55,995
-37,505
-40% -$2.03M
2024 Q2
2 quarters
TDC icon
37
Teradata
TDC
$2.91B
$3.06M 0.59%
98,201
-11,899
-11% -$372K
2024 Q3
1 quarter
VNT icon
38
Vontier
VNT
$4.5B
$3.06M 0.59%
+83,841
New +$3.09M
2024 Q4
0 quarters
EMBC icon
39
Embecta
EMBC
$365M
$3M 0.58%
145,384
-17,616
-11% -$289K
2022 Q3
9 quarters
LEA icon
40
Lear
LEA
$5.99B
$3M 0.58%
+31,700
New +$3.16M
2024 Q4
0 quarters
HALO icon
41
Halozyme
HALO
$13.8B
$2.96M 0.57%
+62,000
New +$3.18M
2024 Q4
0 quarters
NXT icon
42
Nextpower Inc. Common Stock
NXT
$12.7B
$2.96M 0.57%
+81,000
New +$2.97M
2024 Q4
0 quarters
VTRS icon
43
Viatris
VTRS
$20.9B
$2.95M 0.57%
237,074
-28,726
-11% -$353K
2020 Q4
16 quarters
TGNA icon
44
DELISTED
TEGNA Inc
TGNA
$2.94M 0.57%
160,859
-19,491
-11% -$341K
2021 Q3
13 quarters
CROX icon
45
Crocs
CROX
$5.98B
$2.87M 0.55%
26,200
+3,700
+16% +$431K
2022 Q1
11 quarters
PVH icon
46
PVH
PVH
$3.94B
$2.86M 0.55%
+27,000
New +$2.77M
2024 Q4
0 quarters
HPQ icon
47
HP
HPQ
$27.8B
$2.86M 0.55%
87,498
-10,602
-11% -$381K
2013 Q2
46 quarters
TRIP icon
48
TripAdvisor
TRIP
$1.1B
$2.85M 0.55%
193,173
-23,407
-11% -$342K
2024 Q3
1 quarter
DOX icon
49
Amdocs
DOX
$6.34B
$2.83M 0.55%
33,269
-4,031
-11% -$354K
2024 Q2
2 quarters
SNX icon
50
TD Synnex
SNX
$20.4B
$2.8M 0.54%
23,904
-2,896
-11% -$347K
2023 Q3
5 quarters
1
2
3 4 5

Similar funds

BHWM
Bay Harbor Wealth Management Hunt Valley, Maryland $434M AUM 18.95% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
SCP
Seafarer Capital Partners Larkspur, California $434M AUM 22.8% 1-Year Est. Return
CCMI
Creative Capital Management Investments San Diego, California $433M AUM 20.68% 1-Year Est. Return
DCM
Divisar Capital Management San Francisco, California $434M AUM 170.22% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
SWA
Shah Wealth Advisors Chino Hills, California $433M AUM

Clark Estates Inc's Q4 2024 Portfolio in Review

As of Q4 2024, Clark Estates Inc held 101 positions worth $517M, down 3.7% from $537M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Clark Estates Inc's Q4 2024 filing shows 11 new, 7 increased, 56 reduced and 9 closed positions. Its largest new stake was Baxter International: 775,000 shares worth $22.6M. The largest sale was United Therapeutics, an estimated $4.37M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 27% a quarter earlier, followed by Miscellaneous and Technology.

  • Clark Estates Inc's largest Q4 2024 buy was Baxter International: 775,000 shares worth $22.6M.
  • Clark Estates Inc added most to Sony in Q4 2024, an estimated $6.33M increase.
  • Clark Estates Inc's biggest Q4 2024 reduction was L3Harris, cutting an estimated $3.83M.
  • Clark Estates Inc fully exited United Therapeutics in Q4 2024, selling an estimated $4.37M.
  • Clark Estates Inc's ten largest holdings make up 53% of its $517M portfolio in Q4 2024.
  • Clark Estates Inc opened 11 new positions and closed 9 in Q4 2024.
  • Clark Estates Inc's portfolio value fell 3.7% quarter-over-quarter to $517M.

Based on Clark Estates Inc's 13F filing for Q4 2024, filed 6 Feb 2025.